2025-01-16 09:07:04
Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial
Corporate/ 2023-07-24
Everest Medicines Announces that Licensi...

SHANGHAI,March 10,2022-- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner,Venatorx Pharmaceuticals,reported posit...

Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families
Corporate/ 2023-07-24
Fosun Foundation's Second Batch of ...

HONG KONG,March 10,2022-- In the face of the severe fifth wave of epidemic in Hong Kong,Fosun Foundation quickly launched the epidemic relie...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release